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Summary An actinobacterial strain, HG29, with potent activity against pathogenic, toxigenic 
and phytopathogenic fungi was isolated from a Saharan soil sample of Algeria. On the basis of 
morphological and chemotaxonomic characteristics, the strain was classified in the genus 
Streptomyces. Analysis of the 16S rRNA gene sequence showed a similarity level of 99.3% with 
Streptomyces gancidicus NBRC 15412T. The comparison of its cultural and physiological cha­
racteristics with this species revealed significant differences. Moreover, the phylogenetic tree 
showed that strain HG29 forms a distinct phyletic line within the genus Streptomyces. Production 
of antifungal activity was investigated by following kinetics in shake broth. The highest 
antifungal activity was obtained after five days of fermentation, and in the dichloromethane 
extract. Two active compounds, NK1 and NK2, were purified by HPLC using a C18 column. Their 
chemical structures were identified through nuclear magnetic resonance experiments and mass 
spectrometry as oligomycins E and A, respectively, which have not been reported to be produced 
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by S. gancidicus. The two bioactive compounds exhibited significant antifungal activity in vitro 
showing minimal inhibitory concentrations (MICs) values between 2 and 75 µg/mL. 
Introduction 
Filamentous fungi cause a wide range of infectious diseases 
in humans, animais and plants [1,2]. ln addition, their ability 
to produce mycotoxins such as aflatoxins, ochratoxins and 
patulin can be harmful to humans and animais at certain 
concentrations after ingestion of contaminated food and 
feed [3]. Current antifungal compounds are limited in their 
ability to treat infections due to the increase of the resis­
tance in fungi and the toxicity of a wide range of antifungal 
molecules in use such as polyenes [4,5]. This phenomenon 
motivates the search for new bioactive compounds with 
strong activity against pathogenic fungi. ln order to find 
new solutions, several approaches were developed, includ­
ing the search for new antifungal compounds from micro­
organisms [6]. The actinobacteria are known as the most 
attractive source of several types of bioactive metabolites, 
especially members of the genus Streptomyces, which pro­
duce over two-thirds (70%) of the clinically useful antibiotics 
of natural origin [7]. The Algerian Saharan soils are rich and 
diversified in actinobacteria with interesting antimicrobial 
properties [8-13]. 
ln this paper, we describe the taxonomy of an actinobac­
terial strain isolated from a Saharan soil sample, during a 
primary screening program to search for antimicrobial 
compounds. The strain, designated HG29, showed an inter­
esting antifungal producing potential active against several 
pathogenic and toxigenic species of filamentous fungi. Two 
active compounds were purified, and their structures and 
activities were determined. 
Materials and methods 
Strain isolation and maintenance 
The actinobacterial strain HG29 was isolated from a Saharan 
soil sample collected from Hoggar, Tamanrasset (Southern 
Algeria, 22°491N, 5°25'E), by serial dilution agar plating 
method using chitin-vitamin B agar [14], supplemented with 
actidione (80 µg/ml). Pure culture of the strain was main­
tained at 4 °C on ISP4 medium slants. 
Taxonomie studies of HG29 strain 
The morphological characteristics were investigated using the 
media of the International Streptomyces Project (ISP2, ISP3 
and ISP4) [15], Bennett medium and nutrient agar [16] after 7, 
14 and 21 days of incubation at 30 °C. The mycelia organiza­
tion and sporulation were observed by light microscopy. 
For the chemotaxonomic analysis, biomass was obtained 
from cultures grown in shake flasks (250 rpm) using ISP2 
medium. After 5 days of incubation at 30 °c, cells of strain 
HG29 were harvested by centrifugation, washed twice with 
distilled water and hydrolyzed for diaminopimelic acid iso­
mers [ 17], whole-cell sugar pattern [ 1 8] and phosphol i pids 
analyses [19]. 
For the physiological characteristics, 79 tests were per­
formed according to the methods of Locci [20]. They concer­
ned the production of melanoid pigments on ISP6 and ISP7 
media and nitrate reductase, the assimilation of 26 carbohy­
drates and derivatives as sole carbon source, the utilization of 
9 amino acids as sole nitrogen sources, the degradation of 7 
organic acids on ISP9 medium, hydrolysis of 11 organic 
compounds (adenine, guanine, xanthine, casein, Tween 80, 
gelatin, starch, cellulose, esculin, arbutin and urea), the 
sensitivity to 5 different inhibitory compounds including violet 
crystal (0.05%), sodium azide (0.02%), potassium tellurite 
(0.01%), phenol (0.1%) and lysozyme (0.005%), the growth 
in the presence of different concentrations of NaCl (0 2 3 5 
7, 9 and 10% w/v), at different temperatures (25, 30'. 35, '..m'. 
45 and 50 °C) and various pH values (3, 5, 7, 9 and 10). Ail the 
tests were performed at 30 °C (except for temperature tests) 
and observations were recorded at 7, 14 and 21 days. 
For molecular analysis, the DNA of the strain HG29 was 
extracted with a DNA extraction kit (MasterPure ™ Gram 
Positive DNA Purification Kit, Epicentre® Biotechnologies, 
Madison, WI). The 16S rRNA gene was amplified by PCR using 
two primers, 10-30F (5'-GAGTTTGATC-CTGGCTCA-3') and 
1500R (5'-AGAAAGGAGGTGATCCAGCC-3'), as described by 
Rainey et al. [21]. 
Amplification was carried out in a 50 µL reaction volume 
containing 1.5 U of AmpliTaq Gold Taq polymerase (Applied 
Biosystems, Foster City, CA), dNTPs (0.25 mM each), 1 µM of 
each primer, and 100 ng of genomic DNA. Reaction condi­
tions were: 97 °C for 4 min, followed by 35 cycles of 97 °c for 
45 s, 52 °C for 45 s, and 72 °C for 45 s, with a final elongation 
step at 72 °C for 10 min. The amplified products were visua­
lized on a 0.8% (w/v) agarose gel stained with ethidium 
bromide. PCR products were purified with a purification 
kit (Qiagen, Hilden, Germany). The primers used for 
sequencing are listed in Coenye et al. [22]. 
For the 16S rRNA gene phylogenetic analyses, the 
sequence obtained was compared for similarity with sequen­
ces present in the EzTaxon-e server (http://www.eztaxon-e. 
ezbiocloud.net/; [23]). The sequences were aligned with 
reference sequences of representatives of the genus Strep­
tomyces retrieved from the GenBank database. Phylogenetic 
analyses were conducted using Molecular Evolution Genetics 
Analysis (MEGA) software version 5.0 [24]. Phylogenetic 
trees were constructed using the neighbor-joining method 
of Saitou and Nei [25]. The resulting topologies of trees were 
evaluated by bootstrap analyses [26] on 1000 replicates. 
Primary screening for antimicrobial activity 
Antimicrobial activity of the strain HG29 against fungi and 
bacteria was detected using the agar cross streak method. 
The actinobacterium was streaked as a dense straight line on 
ISP2 medium plates and incubated at 30 °C for 10 days. After 
good growth, target strains were streaked at a right angle to 
HG29 strain, and then incubated at 30 °C for 48 h. The 
antimicrobial activity was evaluated by measuring the dis­
tance of inhibition between the target-microorganisms and 
the HG29 strain colony margin. Tests were conducted in 
triplicate. 
The target-fungi tested were mostly pathogenic or 
toxigenic for humans, or phytopathogenic strains. They 
included twenty filamentous fungi (Aspergillus carbonarius 
M333, A. niger OT304, A. parasiticus CBS 100926, 
A. westerdijkiae NRRL 3174, A. nidulans KE202, A. terreus
CT290, A. fumigatus CF140, A. flavus NRRL 3251, Fusarium
culmorum, F. equiseti, F. proliferatum, F. graminearum
Fg3, F. sporotrichioides, F. moniliforme, F. oxysporum f.
sp. lini, Fusarium oxysporum f. sp. albedinis, Penicillium
expansum, P. glabrum, Botrytis cinerea and Umbelopsis
ramanniana NRRL 1829) and five strains of Candida albicans
(M1, M2, M3, IPA200 and IPA988). ln addition, four strains of
bacteria (Bacillus subtilis ATCC 6633, Staphylococcus aureus
ATCC 25923, Klebsiella pneumoniae E40 and Pseudomonas
aeruginosa ATCC 27853) were tested. The strains without
accession number resulted from our laboratory collection.
Time course of antifungal activity production 
and growth 
Fermentations were carried out in liquid medium containing 
glucose 1%, peptone 0.5% and MgCI2 0.1% [27]. The seed 
culture was prepared using a spore suspension in sterile 
distilled water with a final optical density (OD600) of 0.1, 
and from a fresh culture of HG29 strain grown on ISP4 
medium at 30 °C for 10 days. One milliliter of the spore 
suspension was inoculated into Erlenmeyer flasks (250 ml) 
containing 50 ml of the seed medium consisting of (g/L): 4 
beef extract; 1 yeast extract; 4 peptone; 2.5 NaCI and 10 
glucose, pH 7.2 [27]. The Erlenmeyer flasks were prepared 
and incubated on a shaker (250 rpm) at 30 °C for 48 h. 
Aliquots (5%, v/v) of this seed culture were transferred into 
100 ml of the fermentation medium in 500-mL Erlenmeyer 
flasks. The cultures were incubated on a rotary shaker 
(250 rpm) at 30 °C for 10 days. The antifungal activity pro­
duction, the pH and the dry cell weight (DCW) were measu­
red every 24 h. 
The antifungal activity was evaluated by agar well diffu­
sion method against Aspergillus carbonari us M333. The spore 
suspension was prepared in sterile distilled water and adjus­
ted as inoculum to a final concentration of 1 to 2 x 106 CFU/ 
ml. An amount of 20 ml of Sabouraud agar (10 g/L agar) was
inoculated with 15 µL of spore suspension and then poured
into a Petri dish. The plates were kept at room temperature
for 30 min to allow the medium to solidify. Four wells of
10 mm diameter were aseptically bored into the culture
medium, and 200 µL of each culture supernatant were loa­
ded in each well. The plates were incubated at 30 °C for 48 h
after a diffusion process of 2 h at 4 °C. Diameters of the
inhibition zones around the wells were measured. The results
were expressed as mean ± standard deviation (SD) from
triplicate experiments. Growth was studied by determining
the DCW using the method of Bou ras et al. [28].
Extraction and purification of antifungal 
compounds 
For the production of antibiotics, repeated fermentations 
were carried out to obtain a total of 4.0 L of culture broth. 
Extraction of antifungal compounds from the culture filtrate 
was carried out on the day of optimal antifungal activity 
production. The culture broth was centrifuged at 5000 g for 
15 min. The culture filtrate obtained was extracted with 
dichloromethane solvent (1 :1 v/v). The organic phase was 
concentrated with a rotary evaporator at 40 °C. The dry 
crude extract was dissolved in methanol and bioassayed 
against A. carbonarius M333 by the paper disk diffusion 
method. Each paper disk (6 mm diameter) was impregnated 
with 40 µL of the crude extract. Ali paper disks prepared 
were then air dried, sterilized under UV and then placed on 
the surface of Sabouraud agar, previously inoculated with 
A. carbonarius M333 as the target-fungus. Then, the plates
were kept at 4 °C for 2 h to allow the diffusion of antifungal
substances in the medium. Afterwards, the plates were
incubated at 30 °C for 48 h. The antifungal activity was
determined by measuring the diameters of inhibition zones
around each paper disk.
The purification and the analysis of the crude extract 
were carried out by HPLC (Agilent Technologies). The equip­
ment consisted of a variable wavelength detector (UV-Vis 
G1315D detector array), a pump system G1311C, and an 
auto-sampler G1329B. Data were acquired using Agilent 
ChemStation (Rev. B 04.03) software. The stationary phase 
consisted of a C18 reverse-phase column (Zorbax SB, 5 µm, 
9.6 x 250 mm). The samples were analyzed by continuous 
linear gradient solvent system from 40 to 100% methanol in 
water during 25 min, using a flow rate of 1 ml/min and ultra 
violet detection at 220 nm. Fractions were collected sepa­
rately, concentrated and bioassayed against A. carbonarius 
M333 by the paper disk diffusion method. 
Spectroscopie and spectrometric analyses 
The UV-visible of the active compounds was determined in 
methanol solution with a Perkin-Elmer Lambda 20 UV /Vis 
spectrophotometer. The mass spectrum was recorded with a 
LCQ ion-trap mass spectrometer (Finnigan MAT, San Jose, 
California, USA) equipped with a nanospray ion electro-spray 
ionization ESI source (positive and negative ion mode). 1 H 
and 13C NMR spectroscopy were used for the characterization 
of the active molecules. NMR sample was prepared by dis­
solving 2 mg of each purified compound in 600 µL of MeOD. 
Ali spectra were recorded on a Bruker Avance 500 spectro­
meter equipped with a 5 mm triple resonance inverse z­
gradient probe (TBI 1H, 31P, BB). Ali chemical shifts for 1H 
and ne are relative to TMS using 1 H (residual) or ne chemical 
shifts of the solvent as a secondary standard. The tempera­
ture was set at 298 K. Ali the 1 H and 13C signais were assigned 
on the basis of chemical shifts, spin-spin coupling constants, 
splitting patterns and signal intensities, and by using 1H-1H 
COSY45, 1H-13C HSQC, 1H-13C HMBC and nc_1H experi­
ments. Gradient-enhanced 1 H COSY45 was realized included 
24 scans per increment. 1H-13C correlation spectra using a 
gradient-enhanced HSQC sequence (delay was optimized for 
1 JcH of 145 Hz) was obtained with 48 scans per increment. 
Gradient-enhanced HMBC experiment was performed allow­
ing 62. 5 ms for long-range coupling evolution (340 scans were 
accumulated). Typically, 2048 t2 data points were collected 
for 320 t1 increments. 
Minimal inhibitory concentrations 
The minimal inhibitory concentrations (MICs) were determi­
ned by the conventional agar dilution method [29]. 
The target-microorganisms included fifteen filamentous 
fungi (Aspergillus carbonarius M333, A. niger OT304, 
A. parasiticus CBS 100926, A. westerdijkiae NRRL 3174, 
A. nidulans KE202, A. terreus CT290, A. fumigatus CF140, 
A. flavus NRRL 3251, Fusarium culmorum, F. equiseti, 
F. proliferatum, F. oxysporum f. sp. lini, Penicillium expan­
sum, P. glabrum and Umbelopsis ramanniana NRRL 1829), 
one yeast (Candida albicans C200) and four bacteria (Bacillus 
subtilis ATCC 6633, Staphylococcus aureus ATCC 25923, 
Klebsiella pneumoniae E40 and Pseudomonas aeruginosa 
ATCC 27853). Suspensions of target-microorganisms were 
prepared in sterile distilled water with an inoculum size of 
1 x 106 to 3 x 106 CFU/ml for fungi and 108 CFU/ml for 
bacteria. The stock solutions were prepared by dissolving 
3 mg of each antifungal powder in 3 ml of methanol. The 
agar media (Mueller Hinton for bacteria and Sabouraud for 
fungi) were supplemented with different concentrations of 
the antifungal compound (0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 20, 30, 
40, 50, 75 and 100 µg/ml) and then poured into Petri dishes. 
Two standard antifungal drugs, amphotericin B (AMB) and 
itraconazole (ITR) were used as the positive controls. A 
negative control was included in the test by inoculating 
the target-microorganisms onto the media without the anti­
fungal compounds. The agar surface of the plates containing 
a concentration of antifungal agent and the control plates 
were spot inoculated with 1 µL of the suspension of each 
target-microorganism. The plates were incubated for 24- 
48 h at 37 °C for bacteria and 48-72 h at 28 °C for fungi. 
Tests were performed in duplicate. The MICs were determi­
ned as the lowest concentration of the antifungal compound
that inhibited the growth of the target-microorganism, as 
determined by the lack of visual growth compared to the 
negative control. 
Results and discussion 
Taxonomy 
Good growth of strain HG29 was observed on ISP2, ISP4 and 
Bennett media. The growth was moderate on ISP3 and weak 
on nutrient agar medium. At maturity, the aerial mycelium 
was dark greenish blue and produced spirals chains with 3-8 
coils, each chain borne by a short sporophore and containing 
10-50 spores (ESM Fig. 1 ). The substrate mycelium was pale
beige and non-fragmented, producing a brownish soluble
pigment on ISP2 and Bennett media.
Strain HG29 contained LL-diaminopimelic acid isomer and 
glycine. Whole-cell hydrolysates contained galactose, glu­
cose, ribose and traces of mannose, which are typical of cell­
wall type IC [18]. Diagnostic phospholipid detected was 
phosphatidylethanolamine corresponding to type PII phos­
pholipids [30]. Based on the chemotaxonomic and morpho­
logical properties, strain HG29 was identified as a member of 
the genus Streptomyces [31]. 
The physiological characteristics of strain HG29 are given 
in Table 1. The strain produced melanoid pigments on the 
ISP6 and ISP7 media and nitrate reductase. Growth occurred 
at temperatures between 25 and 45 °C, at pH 5, 7 and 9 and 
at a sait concentration of 9% NaCl (w/v). lt can utilize ail 
major organic compounds tested except dulcitol, erythritol, 
melezitose, sorbose, trehalose, glycine, histidine, trypto­
phane, valine, adenine, cellulose, guanine, benzoate and 
tartrate. lt was unable to grow in the presence of crystal 
violet (0.05%), potassium tellurite (0.01%) and sodium azide 
(0.02%). 
The phylogenetic analysis using the 16S rRNA gene 
sequence (1406 nucleotides) confirmed that HG29 strain 
belonged to the genus Streptomyces. The sequence 
was deposited in GenBank under the accession number 
Streptomyces gancidicus NBRC 15412 T (AB 184660) 
.+----------Streptomyces werraensis NBRC 13404T (AB184381) 
Streptomyces pseudogriseolus NBRC 12902T (AB184232) 
Streptomyces capil/ispira/is NBRC 14222T (AB184577) 
Streptomyces cellulosae NBRC 13027T (AB184265) 
�--------Streptomyces minutiscleroticus NBRC 13000T (AB184249) 
�---------Streptomyces carpinensis NBRC 14214T (AB184574) 
Streptomyces azureus NBRC 12744T (AB184837) 
'--------Streptomyces levis NBRC 15423T (AB184670) 
L....------------- ♦ Strain HG29 (KP868649) 
�----------Streptomyces spinoverrucosus NBRC 14228T (AB184578) 
�-----< 
'--------Streptomyces purpurascens NBRC 13077T (AB184859) 
�------ Streptomyces lusitanus NBRC 13464T (AB184424) 
�-------< 
'--------------Streptomyces matensis NBRC 12889T (AB184221) 
0.001 
Figure 1 Phylogenetic tree derived from nearly complete 16S rRNA gene sequences showing relationships between the strain HG29 
and the related type species of the genus Streptomyces. The tree was constructed using the neighbor-joining method. Bootstrap 
values are indicated at nodes (2: 50%). Bar 0.001 substitutions per nucleotide position. 
Table 1 Physiological characteristics of strain HG29. 
Test 
Hydrolysis of 
Adenine 
Arbutin 
Casein 
Cellulose 
Esculin 
Guanine 
Starch 
Tween 80 
Gelatin 
Urea 
Xanthine 
Carbone source utilization (1% w/v) 
Adonitol 
Arabinose 
Cellobiose 
Dextrin 
Dulcitol 
Erythritol 
Fructose 
Fucose 
Galactose 
Glucose 
Glycerol 
lnositol 
Lactose 
Maltose 
Mannitol 
Mannose 
Melezitose 
Melibiose 
Raffinose 
Rhamnose 
Ribose 
Sucrose 
Sorbitol 
Sorbose 
Trehalose 
Xylose 
Nitrogen source utilization (0.1% w/v) 
L-Alanine
L-Asparagine
Glycine
L-Histidine
L-Proline
L-Serine
L-Threonine
L-Tryptophane
L-Valine
Decarboxylation of sodium salts 
Acetate 
Benzoate 
Citrate 
Oxalate 
Propionate 
Pyruvate 
Tartrate 
Result 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Table 1 (Continued) 
Test 
Growth in presence of(% w/v) 
Crystal violet (0.05%) 
Phenol (0.1%) 
Potassium tellurite (0.01%) 
Sodium azide (0.02%) 
Lysozyme (0.005%) 
Growth at 
pH 3 
pH 5, 7, 9 
pH 10 
T 25, 30, 35, 40, 45 °C 
T 50 °C 
NaCl 0-9% 
NaCl 10% 
Nitrate reductase 
Production of melanoid pigments 
ISP6, ISP7 
+: positive test; -: negative test; ±: doubtful. 
Result 
+ 
+ 
+ 
± 
+ 
+ 
± 
+ 
+ 
Table 2 Antimicrobial activity of Streptomyces sp. HG29 by 
the agar cross streak method. 
Target-fungi 
Aspergillus carbonarius M333 
A. niger OT304
A. parasiticus CBS 100926
A. westerdijkiae NRRL 3174
A. nidulans KE202
A. terreus CT290
A. fumigatus CF140
A. flavus NRRL 3251
Fusarium equiseti
F. moniliforme
F. sporotrichioides
F. cu/morum FC200
Fusarium oxysporum f. sp. a/bedinis
F. oxysporum f. sp. lini 
F. graminearum Fg3
F. proliferatum
Penicillium glabrum
P. expansum 
Botrytis cinerea 
Umbelopsis ramanniana NRRL 1829
Candida a/bicans IPA200
C. albicans IPA988 
C. a/bicans M1
C. a/bicans M2
C. albicans M3
Bacil/us subtilis ATCC 6633
Staphy/ococcus aureus ATCC 25923
Klebsiel/a pneumoniae E40
Pseudomonas aeruginosa ATCC 27853
Distance of 
inhibition (mm) 
39.0 ± 1.0 
37.3 ±0.6 
22.5 ± 0.5 
18.3 ± 0.6 
5.7 ± 1.1 
4.5 ± 0.5 
3.3 ± 0.6 
2.1 ± 0.8 
34.0 ± 1.0 
32.6 ±0.6 
27.7 ± 0.6 
26.0 ± 1.0 
26.8 ±0.8 
25.0 ± 1.0 
20.0 ± 1.0 
20.3 ±0.6 
27.6 ±0.6 
27.0±1.0 
27.0±1.0 
4.8 ± 1.2 
3.8 ± 0.8 
3.0 ± 1.0 
2.8 ± 0.8 
5.2 ± 0.8 
6.2 ± 1.2 
20.0 ± 1.0 
13.5 ± 1.3 
0.0 
0.0 
Values are mean ± SD of three independent experiments. 
 KP868649. The highest similarity Level was 99.3% with Strep· 
tomyces gancidicus NBRC 15412T. The phylogenetic tree 
illustrated in Fig. 1 showed that the HG29 strain forms a 
distinct phylogenetic position with closely related species of 
the genus Streptomyces. However, our strain could be dis· 
tinguished from S. gancidicus by some phenotypic properties 
such as the color of aerial mycelium (gray for S. gancidicus), 
the production of melanoid pigments on ISP6 and ISP7 media, 
the utilization of cellobiose, raffinose, sucrose and trypto· 
phane, the decarboxylation of sodium citrate and growth in 
presence of lysozyme [32]. 
Primary screening of antimicrobial activity 
The results of the screening for antimicrobial activity of 
strain HG29 are displayed in Table 2. Streptomyces sp. 
HG29 showed an antifungal activity against ail the fungi 
tested. The antifungal activity was significantly strong 
(> 30 mm) against Aspergillus carbonarius M333, A. niger 
OT304, Fusarium equiseti and F. moniliforme; strong to 
moderate (21-30 mm) against F. sporotrichioides, Penicil· 
lium glabrum, P. expansum, Botrytis cinerea, A. parasiticus 
CBS 100926, F. culmorum FC200, F. oxysporum f. sp. 
albedinis and F. oxysporum f. sp. lini, and moderate 
(10-20 mm) against A. westerdijkiae, F. proliferatum and 
F. graminearum. However, a weak antifungal activity was 
detected (< 10 mm) against A. nidulans KE202, A. terreus 
CT290, A. fumigatus CF140, A. flavus NRRL 3251, Umbelopsis 
ramanniana NRRL 1829 and all tested yeasts.
The antibacterial activity was moderate against Bacillus 
subtilis ATCC 6633 and Staphylococcus aureus ATCC 25923, 
but no activity was found against f. coli ATCC 10536 and 
Klebsiella pneumoniae E40. 
 
Consequently, A. carbonarius M333, the most sensitive 
strain, was selected as the indicator fungus for determining 
the antifungal activity in shake culture media. 
Time course of antifungal activity production 
and growth 
The kinetics of antibiotic production, growth and pH were 
investigated in shake medium, as shown on Fig. 2. The 
antifungal activities were detected on the first day of fer• 
mentation against A. carbonarius M333, reaching a maximum 
the 5th day. The antifungal activity production was found to 
be correlated with the cell growth. The pH decreased to an 
acid state until the 3rd day and then increased gradually 
and reached its maximum (pH 8.2) on the 10th day of 
fermentation. 
Isolation and purification of antifungal 
compounds 
Streptomyces sp. HG29 was grown for five days. The anti· 
fungal substances were extracted with dichloromethane 
from the culture filtrate. The active dichloromethane 
extract was subjected to HPLC analysis to determine the 
antifungal metabolite profiles. The HPLC profile showed two 
major peaks active against A. carbonarius M333, and were 
designed as NK1 (retention time (RT) = 14.99 min) and NK2 
(RT = 15. 77 min). These two peaks were collected and re· 
injected into the HPLC system until total purification was 
achieved (ESM Fig. 2). The pure bioactive compounds had a 
light yellowish color. 
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Figure 2 Time course of pH, growth (dashed curve) and antifungal activity production (solid curve) against Aspergillus carbonarius
M333. Values include the diameter of the well (10 mm). Each measure represents average ± standard deviation from three replicates 
per treatment. 
Spectroscopie studies 
The UV-visible spectra of the pure products NK1 and NK2 
exhibited Âmax at 240 nm (NK1 ), and 232 nm (NK2) in MeOH. 
The mass spectra were obtained in positive and negative 
mode. The molecular weights of the active compounds are 
M = 820 (NK1) and M = 790 (NK2). 
Table 3 1 H and ne NMR data assignments of NK1 and NK2 
compounds in CD3CN at 298 K (See Figs. 3 and 4 for numbering 
of hydrogen and carbon atoms). 
1 H and ne number 1 H chemical shift, ppm ne chemical 
shift, ppm 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
NK1 
1.25 
3.99 
1.47 
4.58 
2.25 
0.98 
2.18-3.04 
1.28 
4.13 
2.10 
1.11 
5.05 
1.68 
1.44 
1.93 
1.31-1.46 
0.88 
5.21 
6.03 
6.13 
5.46 
2.05-2.12 
1.86 
1.03 
3.75 
1.11 
1.14 
3.71 
4.10 
2.63 
1.07 
1.04 
2.80 
3.86 
2.46 
1.19 
6.85 
5.91 
NK2 
1.23 
3.98 
1.37 
4.05 
1.59 
0.95 
1.45-2.16 
1.19-1.97 
0.99 
1.79 
3.87 
2.06 
0.94 
5.01 
1.58 
1.44-1.66 
1.90 
1.31-1.44 
0.89 
5.22 
6.02 
6.15 
5.47 
2.07-2.14 
1.88 
1.04 
3.78 
1.10 
1.17 
3.75 
4.08 
2.63 
1.06 
1.04 
2.80 
3.87 
2.45 
1.18 
6.81 
5.89 
NK1 
23.60 
63.60 
41.60 
67.35 
36.95 
11.64 
43.55 
207.8 
97.55 
20.57 
73.9 
70.39 
35.90 
8.37 
73.98 
41.17 
30.97 
46.00 
28.50 
11.16 
136.45 
131.39 
132.50 
130.18 
38.17 
33.71 
13.70 
72.90 
82.80 
21.12 
221.71 
13.60 
42.39 
72.78 
47.54 
7.43 
217.50 
7.60 
44.30 
72.88 
41.13 
17.00 
149.63 
121.94 
165.33 
NK2 
23.69 
63.79 
42.23 
67.23 
30.37 
10.16 
26.28 
25.60 
98.90 
10.76 
37.67 
68.33 
36.19 
5.87 
76.26 
42.37 
31.24 
46.00 
28.50 
11.14 
136.68 
131.22 
132.56 
130.11 
38.49 
33.81 
13.80 
72.90 
82.90 
21.15 
220 
13.75 
42.36 
72.84 
47.65 
7.43 
217 
8.13 
44.45 
72.81 
41.23 
16.97 
149.30 
122.14 
165.46 
The 1 H and ne chemical shifts of NK1 and NK2 compounds 
are given in Table 3 and structures in Figs. 3 and 4. The 13e, 
HSQe and HMBe spectra show 45 carbon signais for NK1 and 
NK2 molecules. lt was possible to discern 3 ketone groups (8c 
207.8 to 221.7), 6 hydroxyl group (8c 63.6 to 82.8), 1 ester 
function (8c 165.33), 6 sp2-hybridized carbons (8c from 121. 9 
to 146.63) and 25 sp3-hybridized carbons (8c 7.4 to 47.5) for 
molecule NK1, 2 ketone groups (8c 217 .0 and 220.0), 1 ester 
function (8c 165.46) and 5 hydroxyl group (8c 63.79 to 82.90), 
6 sp2-hybridized carbons (8c from 122.1 to 149.3) and 27 sp
3- 
hybridized carbons (8c 7.4 to 47.7) for compound NK2. The 
hydrogens of the hydroxyl group are not observed due to 
rapid exchange with MeOD. The 2D 1 H- 1 H permitted the 
establishment of connectivity between the groups of the NK1 
and NK2 molecules. 
a 
b 
20 
6 
- 1H COSY correlation
--IH-13C HMBC con-clation 
Figure 3 Structure of bioactive compound NK1 (a) and HMBe 
and COSY correlations (b). 
42 
20 
6 
Figure 4 Structure of bioactive compound NK2 (a) and HMBC 
and COSY correlations (b). 
The structures of the NK1 and NK2 compounds were 
determined by NMR and mass spectrometry to be oligomycin 
E [33] and oligomycin A [34], respectively. 
Oligomycins are a subfamily of the macrolides class. The 
first oligomycin was described as a new antifungal antibiotic 
produced by Streptomyces diastatochromogenes [35]. Later, 
nine isomers named A, B, C, D, E, F, G, H and I were 
identified. They refer to a closely related molecular species 
whose basic structure consists of a macrolide ring of ketide 
units [36]. The oligomycins A and E differ in two side sub­
stituents [33,34] linked to the carbon in positions 8 and 11, as 
shown on Figs. 3 and 4. Oligomycin A is a highly specific 
inhibitor of mitochondrial ATP synthase that induces apop­
tosis in various cell types [37]. The oligomycin antibiotics are 
also produced by other species of Streptomyces including 
S. bottropensis [38], S. ostreogriseus [39], S. libani [40],
S. griseolus [41], S. avermitilis [42] and S. diastaticus [43].
However, their isolation has so far not been reported from
S. gancidicus. This species produced the gancidin (molecular
weight 210), a non-ribosomal peptide with antitumoral,
antifungal and antibacterial properties [44,45]. The search
for a possible phylogenetic relationship between the strain
HG29 and the strains of oligomycins-producing Streptomyces
was realized by the analysis and comparison of 16S rRNA gene
sequences. The constructed phylogenetic tree (ESM Fig. 3)
indicated that the strain HG29 constituted a distinct phyletic
line with similarity levels ranging from 98 to 95%.
ln addition to their antifungal activity, the oligomycins 
were reported to have other biological activities, including 
insecticidal and nematicidal activities [46] and immunosup­
pressive properties [39]. Oligomycins have not found clinicat 
applications as antifungal agents because of their high toxi­
city to eukaryotic cells. The animal toxicity of oligomycins 
was reported since 1954 by Smith et al. [35]. The toxic levels 
by intravenous or intraperitoneal administration lied bet­
ween 1.25 and 2.5 mg per kg of body weight. As a conse­
quence of these toxic effects, eukaryotic cells may develop 
serious syndromes (including neurological disorders) that 
may degenerate into life-threatening diseases [47]. Conse­
quently, oligomycins are not used therapeutically. They are 
used only in the research for studying mitochondrial function 
and dysfunction, and to modulate ATP synthesis in studies of 
cell or organ functions. They are also used for understanding 
the pathological mechanisms of some diseases such as Par­
kinsonian syndrome or immunodeficiency diseases, where 
mutations in genes encoding subunits of the ATP synthase 
are known to be responsible for human diseases [48,49]. ln 
recent years, several methods were developed by chemical 
modification of the oligomycin A (at the side chain), which 
resulted in compounds with Lower toxic properties than 
oligomycin A [50,51]. 
Determination of the minimum inhibitory 
concentrations 
The obtained results are illustrated in Table 4. The two 
antifungal compounds showed almost the same biological 
activities against the majority of filamentous fungi. The anti­
Aspergillus effects of NK1 and NK2 (MIC, 2-10 µg/ml) deter­
mined with A. carbonarius M333, A. niger OT304, 
A. parasiticus CBS 100926 and A. westerdijkiae NRRL 3174
were comparable or better than those of amphotericin B
(AMB) and itraconazole (ITR). ln contrast, their anti­
Fusarium effects (MIC, 2-30 µg/ml) determined with
F. culmorum, F. equiseti, F. proliferatum and 
F. oxysporum f. sp. lini were comparable to AMB, but much
better than ITR. The anti-Penicillium effect (MIC, 3 µg/ml)
determined with P. expansum and P. glabrum was similar to
AMB and better than that of ITR. However, the MIC values of
the two compounds against C. albicans C200 and ail tested
bacteria were superior to 100 µg/ml.
Regarding the MIC values determined with Aspergillus 
species (MIC, 2-10 µg/ml), Fusarium species (MIC, 2-
30 µg/ml) and Penicillium species (MIC, 3 µg/ml), the 
effects of NK1 and NK2 are very important against these 
molds which are pathogenic and/or toxigenic for humans or 
phytopathogenic. The obtained values are comparable with 
AMB and better than those of ITR. These standard drugs used 
Table 4 Minimum inhibitory concentrations (MIC) of the 
two antifungal compounds NK1 and NK2 produced by the 
strain HG29 and standard antifungal compounds against tar-
get-microorganisms. 
Target-microorganisms MIC (µg/mL) a 
NK1 NK2 AMB ITR 
Aspergillus carbonarius 2 2 10 
M333 
A. westerdijkiae NRRL 8 10 > 100 7
3174
A. flavus NRRL 3251 > 100 > 100 5 
A. parasiticus CBS 100926 4 3 0.5 
A. nidulans KE202 75 75 2 3 
A. niger OT304 4 3 6 
A. terreus CT290 75 75 > 100 5
A. fumigatus CF140 100 100 1 10 
Penicillium expansum 3 3 3 5 
P. gtabrum 3 3 1 5 
Botrytis cinerea 3 3 3 5 
Fusarium cutmorum 4 2 2 > 100
F. equiseti 2 2 1 > 100
F. moniliforme 2 2 2 > 100
F. proliferatum 20 30 > 100 > 100
F. oxysporum f. sp. lini 8 10 3 > 100
Umbetopsis ramanniana > 100 > 100 0.2 > 100
NRRL 1829 
Candida atbicans C200 > 100 > 100 > 100
Bacillus subtilis ATCC > 100 > 100 > 100 > 100
6633 
Staphy/ococcus aureus > 100 > 100 > 100 > 100
ATCC 25923 
Klebsietta pneumoniae > 100 > 100 > 100 > 100
E40 
Pseudomonas aeruginosa > 100 > 100 > 100 > 100
ATCC 27853 
AMB: amphotericin B; ITR: itraconazole. 
a MIC values represent the average of two repetitions. 
as positive controls are potent antifungal compounds [29]. 
The lowest MIC value found was 2 µg/ml against 
A. carbonarius M333 and F. equiseti which were included
in the tests due to their ability to produce mycotoxins
[52,53]. The antimicrobial spectrum of oligomycins discove­
red by Smith et al. [35] was similar to our obtained results
showing a strong activity against several fungal species.
Moreover, at 100 µg/ml, no activity was observed against
Gram-positive and Gram-negative bacteria or yeasts. They
are also similar in solubility properties (soluble in organic
solvents, but insoluble in water). ln our study, oligomycin A
(NK2) showed an ultraviolet absorption maxima at 232 nm,
similar to finding of Smith et al. [35].
Comparison between the distance of inhibition in the 
primary screening (Table 2) and MIC values of oligomycins 
A and E showed a direct correlation, whenever there is a 
strong distance of inhibition, the MIC value is Lower and vice 
versa. Except for the antibacterial activity against 8. subtilis 
ATCC 6633, S. aureus ATCC 25923, detected by the streak 
method with moderate distances of inhibition, while the 
MICs were > 100 µg/ml. This result could be explained by 
the presence of another antibiotic or more, showing anti-
bacterial activity in the fermentation broth of strain HG29. 
Conclusion 
The results of the present study showed that the strain HG29 
produced oligomycins A and E and shared 99.3% similarity 
with Streptomyces gancidicus. However, these two antibio-
tics are not produced by this nearest species. DNA-DNA 
hybridization experiments between strain HG29 and the 
closely related species S. gancidicus should determine 
the originality of strain HG29 or its assignment to the 
S. gancidicus species.
Despite the toxicity of oligomycins against eukaryotic
cells, their extremely high potency against mycotoxigenic 
and phytopathogenic fungi, as well as their antitumor acti-
vity make these antibiotics an attractive scaffold for rational 
design of new chemotherapeutic agents. Further develop-
ment of oligomycin derivatives (chemical modification or 
semi-synthesis) could be potentially useful for reducing the 
toxic effect and improvement of their therapeutic potential. 
On these bases, the possible use of oligomycins to treat 
infectious and non-infectious diseases would be an interest-
ing perspective. Therefore, availability of oligomycins in 
substantial quantities by fermentation could be useful for 
such investigations. Based on the results presented in this 
paper, we propose a potent producer strain of oligomycins A 
and E. 
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